QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, February 1, 2006, 26(5):1407-1417; doi:10.1523/JNEUROSCI.3463-05.2006

This Article Full Text Full Text (PDF) Supplemental data Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (44) Citing Articles via Google Scholar Google Scholar Articles by Schott, B. H. Articles by Düzel, E. Search for Related Content PubMed PubMed Citation Articles by Schott, B. H. Articles by Düzel, E.

 Previous Article  |  Next Article 

Behavioral/Systems/Cognitive
The Dopaminergic Midbrain Participates in Human Episodic Memory Formation: Evidence from Genetic Imaging

Björn H. Schott,^1,3 Constanze I. Seidenbecher,³ Daniela B. Fenker,¹ Corinna J. Lauer,¹ Nico Bunzeck,¹ Hans-Gert Bernstein,² Wolfgang Tischmeyer,³ Eckart D. Gundelfinger,³ Hans-Jochen Heinze,^1,4 and Emrah Düzel^1,5

¹Department of Neurology II and Center for Advanced Imaging and ²Department of Psychiatry, University Hospital of Magdeburg, 39120 Magdeburg, Germany, ³Departments of Neurochemistry and Molecular Biology and ⁴Behavioral Neurology, Leibniz-Institute for Neurobiology, 39118 Magdeburg, Germany, and ⁵Institute for Cognitive Neuroscience, and National Hospital for Neurology and Neurosurgery, University College London, London WC1N 3AR, United Kingdom

Correspondence should be addressed to Björn H. Schott, Klinik für Neurologie II, Otto von Guericke Universität Magdeburg, Leipziger Strasse 44, 39120 Magdeburg, Germany. Email: bschott{at}neuro2.med.uni-magdeburg.de

Recent data from animal studies raise the possibility that dopaminergic neuromodulation promotes the encoding of novel stimuli. We investigated a possible role for the dopaminergic midbrain in human episodic memory by measuring how polymorphisms in dopamine clearance pathways affect encoding-related brain activity (functional magnetic resonance imaging) in an episodic memory task. In 51 young, healthy adults, successful episodic encoding was associated with activation of the substantia nigra. This midbrain activation was modulated by a functional variable number of tandem repeat (VNTR) polymorphism in the dopamine transporter (DAT1) gene. Despite no differences in memory performance between genotype groups, carriers of the (low expressing) 9-repeat allele of the DAT1 VNTR showed relatively higher midbrain activation when compared with subjects homozygous for the 10-repeat allele, who express DAT1 at higher levels. The catechol-O-methyl transferase (COMT) Val108/158Met polymorphism, which is known to modulate enzyme activity, affected encoding-related activity in the right prefrontal cortex (PFC) and in occipital brain regions but not in the midbrain. Moreover, subjects homozygous for the (low activity) Met allele showed stronger functional coupling between the PFC and the hippocampus during encoding. Our finding that genetic variations in the dopamine clearance pathways affect encoding-related activation patterns in midbrain and PFC provides strong support for a role of dopaminergic neuromodulation in human episodic memory formation. It also supports the hypothesis of anatomically and functionally distinct roles for DAT1 and COMT in dopamine metabolism, with DAT1 modulating rapid, phasic midbrain activity and COMT being particularly involved in prefrontal dopamine clearance.

Key words: dopamine transporter; catechol-O-methyl transferase; polymorphism; dopamine; midbrain; episodic memory; fMRI

---

Received May 13, 2005; revised Dec. 13, 2005; accepted Dec. 13, 2005.

Correspondence should be addressed to Björn H. Schott, Klinik für Neurologie II, Otto von Guericke Universität Magdeburg, Leipziger Strasse 44, 39120 Magdeburg, Germany. Email: bschott{at}neuro2.med.uni-magdeburg.de

This article has been cited by other articles:

				S. Zhong, S. Israel, H. Xue, P. C. Sham, R. P. Ebstein, and S. H. Chew A neurochemical approach to valuation sensitivity over gains and losses Proc R Soc B, December 7, 2009; 276(1676): 4181 - 4188. [Abstract] [Full Text] [PDF]

				N. A. Dennis, A. C. Need, K. S. LaBar, S. Waters-Metenier, E. T. Cirulli, J. Kragel, D. B. Goldstein, and R. Cabeza COMT Val108/158 Met Genotype Affects Neural but not Cognitive Processing in Healthy Individuals Cereb Cortex, July 29, 2009; (2009) bhp132v1. [Abstract] [Full Text] [PDF]

				A. M. Morcom, E. T. Bullmore, F. A. Huppert, B. Lennox, A. Praseedom, H. Linnington, and P. C. Fletcher Memory Encoding and Dopamine in the Aging Brain: A Psychopharmacological Neuroimaging Study Cereb Cortex, July 22, 2009; (2009) bhp139v1. [Abstract] [Full Text] [PDF]

				A. Bertolino, L. Fazio, A. Di Giorgio, G. Blasi, R. Romano, P. Taurisano, G. Caforio, L. Sinibaldi, G. Ursini, T. Popolizio, et al. Genetically Determined Interaction between the Dopamine Transporter and the D2 Receptor on Prefronto-Striatal Activity and Volume in Humans J. Neurosci., January 28, 2009; 29(4): 1224 - 1234. [Abstract] [Full Text] [PDF]

				J.-C. Dreher, P. Kohn, B. Kolachana, D. R. Weinberger, and K. F. Berman Variation in dopamine genes influences responsivity of the human reward system PNAS, January 13, 2009; 106(2): 617 - 622. [Abstract] [Full Text] [PDF]

				B. H. Schott, L. Minuzzi, R. M. Krebs, D. Elmenhorst, M. Lang, O. H. Winz, C. I. Seidenbecher, H. H. Coenen, H.-J. Heinze, K. Zilles, et al. Mesolimbic Functional Magnetic Resonance Imaging Activations during Reward Anticipation Correlate with Reward-Related Ventral Striatal Dopamine Release J. Neurosci., December 24, 2008; 28(52): 14311 - 14319. [Abstract] [Full Text] [PDF]

				S. J. Bishop, J. Fossella, C. J. Croucher, and J. Duncan COMT val158met Genotype Affects Recruitment of Neural Mechanisms Supporting Fluid Intelligence Cereb Cortex, September 1, 2008; 18(9): 2132 - 2140. [Abstract] [Full Text] [PDF]

				S. Vale Current Management of the Cognitive Dysfunction in Parkinson's Disease: How Far Have We Come? Experimental Biology and Medicine, August 1, 2008; 233(8): 941 - 951. [Abstract] [Full Text] [PDF]

				K. D'Ardenne, S. M. McClure, L. E. Nystrom, and J. D. Cohen BOLD Responses Reflecting Dopaminergic Signals in the Human Ventral Tegmental Area Science, February 29, 2008; 319(5867): 1264 - 1267. [Abstract] [Full Text] [PDF]

				U. M. Kramer, T. Cunillera, E. Camara, J. Marco-Pallares, D. Cucurell, W. Nager, P. Bauer, R. Schule, L. Schols, A. Rodriguez-Fornells, et al. The Impact of Catechol-O-Methyltransferase and Dopamine D4 Receptor Genotypes on Neurophysiological Markers of Performance Monitoring J. Neurosci., December 19, 2007; 27(51): 14190 - 14198. [Abstract] [Full Text] [PDF]

				N. Bunzeck, H. Schutze, S. Stallforth, J. Kaufmann, S. Duzel, H.-J. Heinze, and E. Duzel Mesolimbic Novelty Processing in Older Adults Cereb Cortex, December 1, 2007; 17(12): 2940 - 2948. [Abstract] [Full Text] [PDF]

				B. H. Schott, L. Niehaus, B. C. Wittmann, H. Schutze, C. I. Seidenbecher, H.-J. Heinze, and E. Duzel Ageing and early-stage Parkinson's disease affect separable neural mechanisms of mesolimbic reward processing Brain, September 1, 2007; 130(9): 2412 - 2424. [Abstract] [Full Text] [PDF]

				P.R. Corlett, G.D. Honey, and P.C. Fletcher From prediction error to psychosis: ketamine as a pharmacological model of delusions J Psychopharmacol, May 1, 2007; 21(3): 238 - 252. [Abstract] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help